Pierre Weiss

This inventor holds 9 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 5 EPO patents. Top assignees: The University of Nantes, National Institute of Health and Medical Research, Chu Nantes. Active years: 1998-2026.

USPTO Granted Patents = 9 (Patent Applications = 1)

% Patents Active = 55.6

CIPO Patents = 1

EPO Patents = 5 (Patent Applications = 7)

Average Co-Inventor Count = 4.5

ph-index = 2

Forward Citations = 103(Granted Patents)

Location History:

Saint Herblain, FR (2013 - 2017)
Nantes, FR (1998 - 2020)

Company Filing History:

6 out of 156

The University of Nantes

patents

5 out of 1,853

National Institute of Health and Medical Research

Centre National De La Recherche Scientifique

patents

5. 1 out of 1

Ecole Nationale Veterinaire

Institut Francais De Recherche Pour L'exploitation De La Mer (Ifremer)

patents

8. 1 out of 15

Institut National De La Santé Et De La Recherche Médicale (Inserm)

10. 1 out of 834,350

Other

patents

where one patent can have more than one assignee

Years Active: 1998-2026

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12708698 - Formulation comprising a phosphocalcic cement and a physical and/or covalent hydrogel of polysaccharides, printable and having ductile mechanical properties for bone regeneration/bone repair (2026-08-18),

2. 10632203 - Silylated biomolecule-based hydrogel for culturing cardiomyocytes and stem cells, and use of the hydrogel thereof for treating heart failure (2020-04-28),

3. 10632154 - Si-HPMC-encapsulated insulin-producing cells for the treatment of type 1 diabetes (2020-04-28),

4. 9968681 - Silylated biomolecule-based hydrogel for culturing cardiomyocytes and stem cells, and use of the hydrogel thereof for treating heart failure (2018-05-15),

5. 9642939 - Macroporous and highly resorbable apatitic calcium-phosphate cement (2017-05-09),

6. 9285360 - Silylated biomolecules (2016-03-15),

7. 8440462 - Use of a hydrogel for the culture of chondrocytes (2013-05-14),

8. 6001394 - Biomaterial composition and method for preparing same (1999-12-14),

9. 5717006 - Composition for biomaterial; preparation process (1998-02-10),

Title: Inventor Pierre Weiss: Pioneering Advances in Diabetes and Cardiac Treatments

Introduction

Pierre Weiss, an innovative inventor based in Nantes, France, has made significant contributions to the fields of diabetes and cardiac health. With a total of eight patents to his name, Weiss focuses on groundbreaking solutions that address critical health issues.

Latest Patents

Among his latest patents, Weiss has developed methods involving Si-HPMC-encapsulated insulin-producing cells for the treatment of type 1 diabetes. This invention aims to utilize insulin-producing cells encapsulated in silanized hydroxypropyl methylcellulose (Si-HPMC) to restore and maintain euglycemia in patients with diabetes. Additionally, he has created a silylated biomolecule-based hydrogel designed to culture cardiomyocytes and stem cells, which serves as a therapy for heart failure, particularly after a myocardial infarction.

Career Highlights

Weiss has collaborated extensively with prominent institutions, including Université de Nantes and the Institut National de la Santé et de la Recherche Médicale. His work in these prestigious organizations demonstrates his commitment to advancing medical research and developing innovative treatments.

Collaborations

Throughout his career, Pierre Weiss has worked alongside esteemed colleagues such as Guy Daculsi and Jérôme Guicheux. These collaborations have undoubtedly enriched his research and invention processes, fostering an environment of shared knowledge and expertise.

Conclusion

Pierre Weiss stands out as a key inventor whose work has the potential to transform how we approach diabetes management and cardiac care. His innovative patents and collaborations highlight his dedication to improving patient health outcomes through advanced medical technologies.